One Year of Long-Acting Cabotegravir and Rilpivirine in People With Human Immunodeficiency Virus and Long Exposure to Antiretroviral Therapy: Data From the SCohoLART StudyCamilla Muccini, Antonella Castagna, Tommaso Clemente et al.|Open Forum Infectious Diseases|2024Cited by 20
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO RegistryDaniele Armenia, Alessio Bellucci, Maurizio Zazzi et al.|Journal of Antimicrobial Chemotherapy|2024Cited by 6
Sexually transmitted infections in people with multidrug-resistant HIVTommaso Clemente, Vincenzo Spagnuolo, Simona Di Giambenedetto et al.|AIDS|2023Cited by 2
Outcomes after a virological failure to first-line second-generation INSTI-based therapy in a real-life settingRebecka Papaioannu Borjesson, Vincenzo Spagnuolo, Camilla Muccini et al.|Journal of Antimicrobial Chemotherapy|2024Cited by 2
Cancer in people with multidrug-resistant HIVTommaso Clemente, Antonio Di Biagio, Riccardo Lolatto et al.|AIDS|2024Cited by 1